| P50 | author | Steven Segal | Q42642018 |
| P2093 | author name string | Rebecca Robinson | |
| | Erin B Lavik | |
| | Cicely A Williams | |
| | James P Bertram | |
| | Nolan T Flynn | |
| P2860 | cites work | Nanoparticle-induced platelet aggregation and vascular thrombosis | Q28191813 |
| | Epidemiology of trauma deaths: a reassessment | Q28235326 |
| | Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors | Q28645681 |
| | Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Q29616413 |
| | Poly (lactide-co-glycolide) nanoparticles containing coumarin-6 for suppository delivery: in vitro release profile and in vivo tissue distribution | Q33206884 |
| | Novel treatment modalities: new platelet preparations and substitutes | Q33338937 |
| | The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices | Q34072262 |
| | RGD modified polymers: biomaterials for stimulated cell adhesion and beyond | Q34223126 |
| | A profile of combat injury | Q35136408 |
| | Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions | Q35597837 |
| | Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others | Q36647460 |
| | Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system | Q38559002 |
| | Nano hemostat solution: immediate hemostasis at the nanoscale. | Q40243410 |
| | Hemophilia: an updated review | Q40417427 |
| | Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion | Q41467300 |
| | Cell-attachment activities of surface immobilized oligopeptides RGD, RGDS, RGDV, RGDT, and YIGSR toward five cell lines | Q41579954 |
| | Platelet activity and in vivo arterial thrombus formation in rats with mild hyperhomocysteinaemia | Q44222757 |
| | Recombinant activated factor VII for adjunctive hemorrhage control in trauma | Q44472174 |
| | Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation. | Q46417574 |
| | The effect of extensible PEG tethers on shielding between grafted thermo-responsive polymer chains and integrin-RGD binding | Q46516827 |
| | Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor | Q50132660 |
| | Prehospital care, importance of early intervention on outcome. | Q53976343 |
| | Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes | Q56386325 |
| | The global burden of injuries | Q58024276 |
| | ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption | Q60775760 |
| | Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators | Q73466463 |
| | Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation | Q73778453 |
| | Synthesis and evaluation of RGD peptidomimetics aimed at surface bioderivatization of polymer substrates | Q77510611 |
| | Substitutes for success | Q77779188 |
| | Polyhemoglobin-fibrinogen: a novel oxygen carrier with platelet-like properties in a hemodiluted setting | Q81408831 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanotechnology | Q11468 |
| P304 | page(s) | 11ra22 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Science Translational Medicine | Q1573955 |
| P1476 | title | Intravenous hemostat: nanotechnology to halt bleeding | |
| P478 | volume | 1 | |